Tate & Lyle (TATE) AI Stock Analysis

• Market Cap: £1.67B
• Dividend Yield: 5.2%
• Average Volume (3M): 2.61M
• Price to Earnings (P/E): 26.7
• Beta (1Y): 0.83
• Revenue Growth: 26.84%
• EPS Growth: -81.73%
• Country: UK
• Employees: 3,318
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Packaged Foods
• EPS (TTM): 0.19
• Shares Outstanding: 445,446,780
• 10 Day Avg. Volume: 2,809,626
• 30 Day Avg. Volume: 2,611,880
• PEG Ratio: -0.61
• Price to Book (P/B): 4.01
• Price to Sales (P/S): 3.67
• P/FCF Ratio: 148.36
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: £487.50
• Price Target Upside: 26.62% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 8
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 59 Neutral
• Price Target: 395.00p ▲(2.60% Upside)

Tate & Lyle's overall stock score reflects a stable financial performance and a strong dividend yield, but is weighed down by bearish technical indicators and challenging market conditions highlighted in the earnings call. The strategic benefits from the CP Kelco merger and strong sucralose demand provide some positive outlook, but current market challenges are significant.

Positive Factors

CP Kelco Merger Success

The successful integration and cross-selling opportunities from the CP Kelco merger enhance Tate & Lyle's market reach and growth potential, indicating a strategic advantage that can drive long-term revenue growth.

Strong Sucralose Demand

Consistent strong demand for sucralose supports stable revenue streams and highlights Tate & Lyle's competitive position in the sweeteners market, contributing to sustained business performance.

Productivity Program on Track

Effective execution of the productivity program ensures operational efficiency, cost savings, and margin improvement, strengthening Tate & Lyle's financial health and competitiveness.

Negative Factors

Revenue and EBITDA Decline

Anticipated declines in revenue and EBITDA reflect challenging market conditions, which may pressure financial performance and limit growth opportunities in the near to medium term.

Challenging Market Conditions

Difficult market conditions, especially in key regions like North America, can impede sales growth and profitability, posing risks to Tate & Lyle's business stability and expansion efforts.

Impact of Tariffs

Tariff impacts can disrupt supply chains and increase costs, potentially eroding margins and affecting Tate & Lyle's competitive positioning in affected markets.

Tate & Lyle Business Overview & Revenue Model

Company Description

Tate & Lyle PLC, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. It operates through three segments: Food & Beverage Solutions, Sucralose, and Primary Products. The company offers texturants; nutritive sweeteners, such as high fructose corn syrup and dextrose; health and wellness ingredients; and stabilizers. It also provides industrial starches for paper, packaging, and industrial adhesives; acidulants, such as citric acid; and commodities comprising corn gluten feed and meal for animal nutrition, as well as corn oil and ethanol. In addition, the company engages in the treasury and insurance businesses; and provision of research and development services. Tate & Lyle PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.

How the Company Makes Money

Tate & Lyle generates revenue through the sale of its ingredients and solutions to food and beverage manufacturers, as well as other sectors such as pharmaceuticals. Key revenue streams include the sale of sweeteners like sucralose and other high-intensity sweeteners, starches, and specialty ingredients aimed at improving the texture, flavor, and health benefits of food products. The company also benefits from partnerships with food manufacturers and beverage companies, providing tailored solutions that enhance product offerings. Additionally, Tate & Lyle invests in innovation and sustainability initiatives, which not only help in reducing costs but also attract customers seeking healthier and more sustainable ingredients. The company's focus on research and development allows it to stay competitive and meet the evolving needs of its clients.

Tate & Lyle Financial Statement Overview

Summary

Tate & Lyle demonstrates a stable financial position with consistent revenue growth and solid profitability margins. The balance sheet shows prudent leverage management, though there are areas for improvement in cash flow consistency and return on equity.

Income Statement

Tate & Lyle has shown a consistent revenue growth with a slight dip in the latest year. The gross profit margin and net profit margin are healthy, although the net profit margin has seen some volatility. EBIT and EBITDA margins indicate stable operational efficiency.

Balance Sheet

The company maintains a moderate debt-to-equity ratio, indicating balanced leverage. The return on equity has been reasonable but slightly declined, suggesting room for improvement in utilizing shareholder funds. The equity ratio is strong, reflecting a solid asset base relative to liabilities.

Cash Flow

Operating cash flow is positive, yet shows fluctuations, affecting free cash flow growth. The company has a stable operating cash flow to net income ratio, demonstrating its ability to convert earnings into cash efficiently.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.56B	1.74B	1.65B	1.75B	1.38B	1.21B
Gross Profit	1.56B	706.00M	851.00M	733.00M	514.00M	481.00M
EBITDA	338.00M	254.00M	345.00M	279.00M	168.00M	292.00M
Net Income	251.00M	143.00M	188.00M	190.00M	236.00M	253.00M
Balance Sheet
Total Assets	2.21B	3.73B	2.28B	2.51B	3.25B	2.97B
Cash, Cash Equivalents and Short-Term Investments	594.00M	334.00M	437.00M	475.00M	112.00M	371.00M
Total Debt	555.00M	1.31B	590.00M	713.00M	679.00M	786.00M
Total Liabilities	1.02B	2.14B	1.04B	1.32B	1.63B	1.51B
Stockholders Equity	1.19B	1.59B	1.24B	1.19B	1.62B	1.45B
Cash Flow
Free Cash Flow	171.00M	43.00M	98.00M	-12.00M	-45.00M	217.00M
Operating Cash Flow	282.00M	164.00M	208.00M	66.00M	103.00M	369.00M
Investing Cash Flow	176.00M	-630.00M	-20.00M	835.00M	-113.00M	-205.00M
Financing Cash Flow	-154.00M	367.00M	-215.00M	-598.00M	-247.00M	-29.00M

Tate & Lyle Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 385.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:TATE, the sentiment is Neutral. The current price of 385 is above the 20-day moving average (MA) of 383.39, below the 50-day MA of 430.60, and below the 200-day MA of 513.02, indicating a neutral trend. The MACD of -11.34 indicates Negative momentum. The RSI at 41.18 is Neutral, neither overbought nor oversold. The STOCH value of 30.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:TATE.

Tate & Lyle Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ABF	77 Outperform	£15.74B	15.62	9.22%	2.85%	-3.06%	-26.93%
CWK	73 Outperform	£2.64B	19.67	14.14%	2.05%	4.77%	18.94%
PFD	69 Neutral	£1.56B	12.65	9.02%	1.58%	1.01%	11.12%
GNC	67 Neutral	£1.01B	19.20	12.12%	0.89%	0.49%	14.18%
HFG	66 Neutral	£576.25M	14.72	12.72%	5.45%	8.58%	-15.81%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
TATE	59 Neutral	£1.67B	26.66	2.48%	5.20%	26.84%	-81.73%

Tate & Lyle Corporate Events

Tate & Lyle Reports Interim Results and Dividend Increase

Tate & Lyle PLC announced its preliminary results for the six months ending 30 September 2025, highlighting an interim dividend of 6.6p per share, up from 6.4p in 2024. The company will host a results presentation led by its CEO and CFO, with a live webcast available for analysts and investors. This announcement reflects Tate & Lyle’s continued commitment to shareholder returns and its strategic growth following the acquisition of CP Kelco, positioning the company as a leader in the food ingredient industry.

The most recent analyst rating on (GB:TATE) stock is a Hold with a £390.00 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.

Tate & Lyle’s Management Shows Confidence with Share Acquisition

Tate & Lyle PLC announced a transaction involving the acquisition of 16,000 ordinary shares by Steve Foots, a Person Discharging Managerial Responsibilities, and Alison Foots, a person closely associated. This transaction, conducted on the London Stock Exchange at a price of £3.699547 per share, aligns with the company’s compliance with the Market Abuse Regulation and reflects the confidence of its management in the company’s future prospects.

The most recent analyst rating on (GB:TATE) stock is a Buy with a £4.60 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.

Tate & Lyle Director Increases Stake with ADR Purchase

Tate & Lyle PLC announced a transaction involving Claudia Vaz de Lestapis, a non-executive director, and Alexandre Samuel Pierre Marie de Lestapis, who acquired 2,500 American Depositary Receipts (ADRs) at a price of US$20.16 each. This acquisition increases their total holding to 5,000 ADRs, equivalent to 20,000 ordinary shares, and was conducted on the OTCQX exchange. This transaction reflects the confidence of key stakeholders in the company’s future prospects and complies with the Market Abuse Regulation.

The most recent analyst rating on (GB:TATE) stock is a Buy with a £4.60 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.

Tate & Lyle CEO Increases Stake with Share Purchase

Tate & Lyle PLC announced a significant transaction involving its CEO, Nick Hampton, who acquired 25,000 ordinary shares at a price of £3.688 each, increasing his total shareholding to 951,816 shares. This transaction, conducted on the London Stock Exchange, highlights a vote of confidence in the company’s future prospects by its leadership, potentially impacting investor perceptions and market positioning.

The most recent analyst rating on (GB:TATE) stock is a Hold with a £4.30 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.

Tate & Lyle Director Increases Stake with ADR Purchase

Tate & Lyle PLC announced that Glenn Fish, a non-executive director and person discharging managerial responsibilities, acquired 1,000 American Depositary Receipts (ADRs) at a price of US$20.50 each. This transaction, conducted on the OTCQX exchange, increases Mr. Fish’s total interest to 5,049.828 ADRs, representing 20,199.3 shares in the company. The acquisition reflects a strategic move by a key company figure, potentially signaling confidence in the company’s future performance and stability.

The most recent analyst rating on (GB:TATE) stock is a Hold with a £4.30 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.

Tate & Lyle Reports Progress Amid Market Challenges

Tate & Lyle PLC has issued a pre-close statement ahead of its six-month results announcement, highlighting strong customer engagement and early cross-selling successes following its combination with CP Kelco. Despite a slowdown in market demand impacting short-term financial performance, the company is accelerating efforts to drive top-line growth through enhanced customer segmentation and innovation. The integration with CP Kelco is expected to deliver revenue and cost synergies, positioning Tate & Lyle for improved performance in the future, despite current economic volatility.

The most recent analyst rating on (GB:TATE) stock is a Buy with a £6.50 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.

Tate & Lyle Updates Share Capital and Voting Rights

Tate & Lyle PLC has announced its current issued share capital as of August 29, 2025, which consists of 476,741,354 ordinary shares, with 31,294,579 held in Treasury. This results in a total of 445,446,775 voting rights, which shareholders can use to assess their interests in the company under the Disclosure Guidance and Transparency Rules.

The most recent analyst rating on (GB:TATE) stock is a Hold with a £577.00 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.

Tate & Lyle Director Acquires ADRs, Signaling Confidence

Tate & Lyle PLC announced a transaction involving Glenn Fish, a Non-executive Director, who acquired 89.424 American Depositary Receipts (ADRs) at a price of US$29.31 each, representing an interest in 16,199.3 shares of the company. This transaction, conducted on the OTCQX exchange, reflects managerial confidence in the company’s prospects and complies with the Market Abuse Regulation, potentially impacting stakeholder perceptions positively.

The most recent analyst rating on (GB:TATE) stock is a Hold with a £7.25 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.